Current Issue : July- September Volume : 2012 Issue Number : 3 Articles : 1 Articles
A novel strain of H1N1 swine-origin influenza A virus (S-OIV) emerged in Mexico and the United States, and soon after was declared a pandemic by the World Health Organization. The aim of this study is to evaluate general awareness and attitude towards swine flu amongst the patients. Infection of human being by novel Influenza A H1N1 virus that causes pandemic of swine flu in the world. The estimated incubation period is unknown and could range from 1 to 7 days, although the incubation period for most cases will likely range from 1 to 4 days. The duration of shedding for the novel H1N1 virus is unknown. Infected persons are assumed to be shedding virus from the day prior to onset of illness until resolution of symptoms. The symptoms of infection with Novel Influenza A H1N1 are similar to other forms of influenza, and include fever, cough, headache, pain in the muscles or joints, sore throat, chills, fatigue and runny nose. Only two antiviral agents are recommended by the CDC (Centre for Disease Control) for treatment of novel influenza AH1N1 disease viz. oseltamivir (Tamiflu) and zanamivir18. These two agents are both neuraminidase inhibitors. Viral enzyme neuraminidase functions to detach newly produced virus from the host cell, preventing its release to infect other cells...
Loading....